MedAlliance is a privately held medical technology firm. Its main office is situated in Nyon, Switzerland, and it has establishments in Irvine CA, Glasgow UK, and Singapore. The company's focus has been on the advancement of innovative drug-coated balloons (DCBs) for individuals experiencing severe coronary and peripheral arterial disorders. By utilizing pioneering exclusive technology, MedAlliance has discovered a distinct resolution to the issue of regulated and prolonged sirolimus discharge with SELUTION SLR™.